Wall Street Zen upgraded shares of Adlai Nortye (NASDAQ:ANL – Free Report) from a hold rating to a buy rating in a research report report published on Saturday.
Several other brokerages have also weighed in on ANL. Weiss Ratings reiterated a “sell (e+)” rating on shares of Adlai Nortye in a research report on Tuesday, July 14th. JonesTrading began coverage on shares of Adlai Nortye in a research report on Thursday, May 14th. They issued a “buy” rating and a $22.00 target price on the stock. Oppenheimer initiated coverage on shares of Adlai Nortye in a research note on Thursday, May 28th. They set an “outperform” rating and a $32.00 target price for the company. Finally, Cantor Fitzgerald began coverage on shares of Adlai Nortye in a research report on Monday, June 22nd. They set an “overweight” rating for the company. Five research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $24.25.
Get Our Latest Analysis on Adlai Nortye
Adlai Nortye Stock Performance
Institutional Investors Weigh In On Adlai Nortye
A number of institutional investors have recently modified their holdings of the company. SmartHarvest Portfolios LLC raised its holdings in shares of Adlai Nortye by 8.5% in the 1st quarter. SmartHarvest Portfolios LLC now owns 16,367 shares of the company’s stock valued at $113,000 after buying an additional 1,279 shares during the period. Renaissance Technologies LLC purchased a new position in Adlai Nortye during the 1st quarter valued at about $457,000. ADAR1 Capital Management LLC purchased a new position in Adlai Nortye during the 1st quarter valued at about $816,000. Affinity Asset Advisors LLC acquired a new position in Adlai Nortye in the 1st quarter valued at about $1,140,000. Finally, Seven Fleet Capital Management LP acquired a new position in Adlai Nortye in the 2nd quarter valued at about $1,302,000. 35.21% of the stock is owned by institutional investors and hedge funds.
About Adlai Nortye
Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.
Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.
The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.
Featured Stories
- Five stocks we like better than Adlai Nortye
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for Adlai Nortye Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adlai Nortye and related companies with MarketBeat.com's FREE daily email newsletter.
